Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Ran BP-5 Activators

RanBP5, also known as Importin-9 (IPO9), is a protein that is part of the Ran-binding protein family and functions within the nucleus-cytoplasmic transport system. This system is essential for the directional transport of a variety of molecules, including proteins and RNAs, across the nuclear envelope. RanBP5 is particularly implicated in the nuclear import of proteins possessing a nuclear localization signal (NLS).The transport process hinges on the small GTPase Ran, which exists in a GTP-bound state in the nucleus and a GDP-bound state in the cytoplasm. RanBP5 acts as an adaptor that can bind to import substrates and facilitate their interaction with the nuclear transport receptor Importin-β. This complex then docks at the nuclear pore complex (NPC) and translocates into the nucleus. Upon entry into the nucleus, the high concentration of Ran-GTP induces a conformational change in RanBP5, leading to the release of the cargo.

RanBP5 is also involved in the nuclear export of proteins and RNAs by binding to Exportin-1 (CRM1) in a Ran-GTP-dependent manner, forming a trimeric complex that allows the passage of export cargos out of the nucleus. It also plays a role in the regulation of spindle assembly during mitosis and may be involved in cellular processes such as cell cycle control, differentiation, and signaling.Aberrant function or expression of RanBP5 has been implicated in various diseases, including cancer. It may contribute to the mislocalization of tumor suppressors or oncogenes, leading to altered cell proliferation and survival.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

This compound is a tyrosine kinase inhibitor, but paradoxically, it could lead to compensatory upregulation of ABL1 activity in non-targeted pathways.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Another tyrosine kinase inhibitor that could potentially cause feedback enhancement of ABL1 in untargeted pathways.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

Similar to other tyrosine kinase inhibitors, could induce upregulation of ABL1 through compensatory mechanisms.

AP 24534

943319-70-8sc-362710
sc-362710A
10 mg
50 mg
$175.00
$983.00
2
(1)

By inhibiting certain kinases, this compound might lead to a compensatory activation of ABL1.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

A flavonoid that may influence kinase signaling, potentially leading to indirect enhancement of ABL1.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

As a kinase modulator, EGCG could influence pathways that lead to the activation of ABL1.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

May modulate kinase activity, potentially affecting ABL1 signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

While a PI3K inhibitor, it could indirectly lead to the activation of ABL1 through cross-talk between signaling pathways.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Inhibits MEK, which may alter signaling cascades in a way that compensates with increased ABL1 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

This p38 MAPK inhibitor might enhance ABL1 activity through feedback loops in MAPK signaling.